Meridian Bioscience receives FDA clearance for new molecular diagnostic test

Meridian Bioscience announced that it has received FDA clearance for a new molecular diagnostic test for Bordetella pertussis, its fifth assay on the illumigene platform. This innovative test is the first FDA-cleared molecular stand-alone assay for B. pertussis providing a solution to the unmet need of today’s healthcare market.

View Comments (0)